Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
Birgit Girshick
CEOBirgit Girshick
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
9.98B
Market cap9.98B
Price-Earnings ratio
-53.75
Price-Earnings ratio-53.75
Dividend yield
Dividend yield
Average volume
760.94K
Average volume760.94K
High today
$213.25
High today$213.25
Low today
$200.00
Low today$200.00
Open price
$203.00
Open price$203.00
Volume
254.39K
Volume254.39K
52 Week high
$228.88
52 Week high$228.88
52 Week low
$144.26
52 Week low$144.26

Stock Snapshot

As of today, Charles River(CRL) shares are valued at $207.13. The company's market cap stands at 9.98B, with a P/E ratio of -53.75.

On 2026-06-25, Charles River(CRL) stock moved within a range of $200.00 to $213.25. With shares now at $207.13, the stock is trading +3.6% above its intraday low and -2.9% below the session's peak.

Trading activity shows a volume of 254.39K, compared to an average daily volume of 760.94K.

The stock's 52-week range extends from a low of $144.26 to a high of $228.88.

The stock's 52-week range extends from a low of $144.26 to a high of $228.88.

CRL News

Simply Wall St 10h
Charles River Deepens Lilly AI Partnership: What Does TuneLab Access Mean for Its Moat?

On 18 June 2026, Eli Lilly’s Lilly TuneLab announced a collaboration under which Charles River Laboratories will provide standardized nonclinical testing servic...

Charles River Deepens Lilly AI Partnership: What Does TuneLab Access Mean for Its Moat?
Nasdaq 3d
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?

Key Points Bio-Rad Laboratories offers high profitability and a liquid balance sheet with a current ratio above 5x. Charles River Laboratories International m...

Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
Simply Wall St 4d
Charles River Laboratories International Stock Could Be 41% Undervalued After Lilly Tie Up And Upgrade

Advertisement Charles River Laboratories International stock reacts to new AI drug discovery collaboration Charles River Laboratories International (CRL) is b...

Charles River Laboratories International Stock Could Be 41% Undervalued After Lilly Tie Up And Upgrade

Analyst ratings

75%

of 20 ratings
Buy
75%
Hold
20%
Sell
5%

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.